Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106928136B details graphene palladium cobalt catalysis for montelukast intermediate. Offers high yield and chiral selectivity for reliable pharmaceutical intermediate supply chains.
Patent CN109608488A reveals Ru-catalyzed route for quinoline derivatives. Offers cost reduction and scalable supply chain solutions for global pharmaceutical intermediates.
Patent CN103319358B details a novel route for 7-aminoheptanoic acid. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis patent CN118666668A offers high purity above 99% and scalable purification for pharmaceutical intermediates supply chain stability and cost efficiency in global manufacturing.
Novel diazotization route ensures high purity pyridine-3-sulfonyl chloride. Reduces waste and enhances supply chain stability for pharmaceutical manufacturing.
Advanced synthesis of 1,3,2'-N,N,N-triacetyl gentamicin C1a via patent CN111040007A. Offers high-purity API intermediates with optimized cost reduction in pharmaceutical manufacturing.
Novel synthesis route for Isepamicin sulfate using Gentamicin B reduces cost and simplifies operation for pharmaceutical manufacturing supply chains globally.
Patent CN100503590C details a novel Rh-catalyzed hydrogenation of L-malic acid diester. This method offers high optical purity and lower pressure conditions for efficient API intermediate manufacturing.
Patent CN114315627B introduces a green ionic liquid-zeolite method for doxycycline intermediates, offering high purity and reduced environmental impact for pharma supply chains.
Advanced synthesis of N-3-isoxazole carbamic acid tert-butyl ester via patent CN109369553B. Delivers high purity, scalable production, and cost-effective supply chain solutions.
Discover the novel preparation method for 16 beta alkyl steroids via CN107746420B. Achieve superior selectivity and yield for pharmaceutical intermediates with reduced costs.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Patent CN112574285B reveals a novel solid-liquid phase synthesis for disulfide-bonded polypeptides, offering high purity and simplified manufacturing for pharmaceutical intermediates.
Patent CN118440041B details a novel seven-step synthesis for high purity chiral intermediates. This method ensures cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN114349754B details a high-yield ionic liquid method for 2,6-dichloropurine, offering pharmaceutical intermediate suppliers a greener, heavy-metal-free production route.
Advanced Pt/Bi catalytic hydrogenation technology for m-aminoacetophenone. Delivers superior selectivity, green processing, and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN105566131B reveals Pt-Bi catalyst method for m-aminoacetophenone. High selectivity, green process, scalable supply chain solution for pharmaceutical intermediates.
Patent CN102234240B details a high-yield L-BMAA synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable supply solutions.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1197837C details a scalable Wittig-Horner route for C15 and C20 polyenoid units. Achieve cost reduction in fine chemical manufacturing via catalytic oxidation.